$128.05
0.860.68%
al cierre: Nov 25, 4:00 PM EST
$127.71
-0.34-0.26%
After hour: 4:47 PM EST
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Abbott Laboratories informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
ene 21
Estimación de BPA
$1.500
Estimación de ingresos trimestrales
$11.79B
Ingresos anuales
(a partir de sept 30)
(a partir de sept 30)
$43.84B
Analice el historial de beneficios de Abbott Laboratories utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ABT | Abbott Laboratories | $1.34 | $1.50 | — | — | $10.97B | $11.79B | — | — | 01/21/2026 | |
ABT | Abbott Laboratories | $1.21 | $1.30 | $1.30 | 0.00% | $10.63B | $11.40B | $11.37B | -0.30% | 10/15/2025 | |
ABT | Abbott Laboratories | $1.14 | $1.25 | $1.26 | 0.80% | $10.38B | $11.04B | $11.14B | 0.91% | 07/17/2025 | |
ABT | Abbott Laboratories | $0.98 | $1.07 | $1.09 | 1.87% | $9.96B | $10.39B | $10.36B | -0.31% | 04/16/2025 | |
ABT | Abbott Laboratories | $1.19 | $1.34 | $1.34 | 0.00% | $10.24B | $11.03B | $10.97B | -0.51% | 01/22/2025 | |
ABT | Abbott Laboratories | $1.14 | $1.20 | $1.21 | 0.83% | $10.14B | $10.55B | $10.63B | 0.81% | 10/16/2024 | |
ABT | Abbott Laboratories | $1.08 | $1.10 | $1.14 | 3.64% | $9.98B | $10.37B | $10.38B | 0.07% | 07/18/2024 | |
ABT | Abbott Laboratories | $1.03 | $0.95 | $0.98 | 3.16% | $9.75B | $9.88B | $9.96B | 0.85% | 04/17/2024 | |
ABT | Abbott Laboratories | $1.03 | $1.19 | $1.19 | 0.00% | $10.09B | $10.18B | $10.24B | 0.60% | 01/24/2024 | |
ABT | Abbott Laboratories | $1.15 | $1.04 | $1.14 | 9.62% | $10.41B | $9.32B | $10.14B | 8.83% | 10/18/2023 | |
ABT | Abbott Laboratories | $1.43 | $1.05 | $1.08 | 2.86% | $11.26B | $9.70B | $9.98B | 2.87% | 07/20/2023 | |
ABT | Abbott Laboratories | $1.73 | $0.99 | $1.03 | 4.04% | $11.89B | $9.64B | $9.75B | 1.11% | 04/19/2023 | |
ABT | Abbott Laboratories | $1.32 | $0.92 | $1.03 | 11.96% | $11.47B | $9.64B | $10.09B | 4.68% | 01/25/2023 | |
ABT | Abbott Laboratories | $1.40 | $0.94 | $1.15 | 22.34% | $10.93B | $9.64B | $10.41B | 7.99% | 10/19/2022 | |
ABT | Abbott Laboratories | $1.17 | $1.12 | $1.43 | 27.68% | $10.22B | $10.29B | $11.26B | 9.40% | 07/20/2022 | |
ABT | Abbott Laboratories | $1.32 | $1.47 | $1.73 | 17.69% | $10.46B | $11.02B | $11.89B | 7.94% | 04/20/2022 | |
ABT | Abbott Laboratories | $1.45 | $1.21 | $1.32 | 9.09% | $10.70B | $10.71B | $11.47B | 7.08% | 01/26/2022 | |
ABT | Abbott Laboratories | $0.98 | $0.94 | $1.40 | 48.94% | $8.85B | $9.54B | $10.93B | 14.55% | 10/20/2021 | |
ABT | Abbott Laboratories | $0.57 | $1.02 | $1.17 | 14.71% | $7.33B | $9.69B | $10.22B | 5.50% | 07/22/2021 | |
ABT | Abbott Laboratories | $0.65 | $1.27 | $1.32 | 3.94% | $7.73B | $10.69B | $10.46B | -2.19% | 04/20/2021 | |
ABT | Abbott Laboratories | $0.95 | $1.35 | $1.45 | 7.41% | $8.31B | $9.94B | $10.70B | 7.66% | 01/27/2021 |
Abbott Laboratories (ABT) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-10-15 | $1.30 | $1.30 | 0.00 % |
| Q2 | 2025-07-17 | $1.26 | $1.25 | 0.80 % |
| Q1 | 2025-04-16 | $1.09 | $1.07 | 1.87 % |
| Q4 | 2025-01-22 | $1.34 | $1.34 | 0.00 % |
Abbott Laboratories (ABT) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-10-15 | $11.37B | $11.40B | -0.30 % |
| Q2 | 2025-07-17 | $11.14B | $11.04B | 0.91 % |
| Q1 | 2025-04-16 | $10.36B | $10.39B | -0.31 % |
| Q4 | 2025-01-22 | $10.97B | $11.03B | -0.51 % |
PREGUNTAS FRECUENTES
¿Cuándo Abbott Laboratories (NYSE:ABT) publicará los resultados?
Está previsto que Abbott Laboratories (ABT) presente resultados el enero 21, 2026. Los últimos resultados se publicaron el octubre 15, 2025 para el Q3.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Abbott Laboratories (NYSE:ABT)?
El BPA real fue de $1.30, que alcanzó la estimación de $1.30.
¿Cuáles fueron los ingresos de Abbott Laboratories (NYSE:ABT)?
Los ingresos reales fueron $11.4B, que no alcanzó la estimación de $11.4B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.